Sutro Biopharma (STRO) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2026)
Powered by 
Analysis
Sutro Biopharma (STRO) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 14.05% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.65% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 411.50% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -3.34% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 16.78% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.66% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 19.96% |
| 10 | Sutro Biopharma | 334.33 Mn | 169.99 Mn | - | -29.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.29% |
| Dec 31, 2025 | -24.38% |
| Sep 30, 2025 | -18.09% |
| Jun 30, 2025 | -14.06% |
| Mar 31, 2025 | -10.31% |
| Dec 31, 2024 | -6.91% |
| Sep 30, 2024 | -6.60% |
| Jun 30, 2024 | 1.31% |
| Mar 31, 2024 | 11.63% |
| Dec 31, 2023 | 19.26% |
| Sep 30, 2023 | 23.21% |
| Jun 30, 2023 | 28.02% |
| Mar 31, 2023 | 36.12% |
| Dec 31, 2022 | 36.73% |
| Sep 30, 2022 | 41.77% |
| Jun 30, 2022 | 36.53% |
| Mar 31, 2022 | 32.87% |
| Dec 31, 2021 | 27.29% |
| Sep 30, 2021 | 25.94% |
| Dec 31, 2020 | -2.60% |